Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$428M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$232M |
| 3 |
Grayscale Bitcoin Trust
GBTC
|
+$208M |
| 4 |
Morgan Stanley Direct Lending Fund
MSDL
|
+$201M |
| 5 |
Infosys
INFY
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$50.9B |
| 2 |
Apple
AAPL
|
+$38.9B |
| 3 |
Amazon
AMZN
|
+$26B |
| 4 |
NVIDIA
NVDA
|
+$23.3B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 10.81% |
| 3 | Healthcare | 9.76% |
| 4 | Consumer Discretionary | 9.08% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPHA
5726
Innate Pharma
IPHA
$164M
| $127K | ﹤0.01% |
44,124
-48,584
| -52% | -$127K |
|
5727
InnovAge Holding
INNV
$1.48B
| $127K | ﹤0.01% |
28,565
-46,989
| -62% | -$247K |
|
5728
Direxion Daily Aerospace & Defense Bull 3X ETF
DFEN
$438M
| $126K | ﹤0.01% |
4,719
-8,459
| -64% | -$198K |
|
|
CALT
5729
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
| $126K | ﹤0.01% |
5,986
+4,782
| +397% | +$106K |
|
5730
Innovator Laddered Allocation Power Buffer ETF
BUFF
$935M
| $125K | ﹤0.01% |
3,000
-3,000
| -50% | -$123K |
|
5731
Lantronix
LTRX
$272M
| $125K | ﹤0.01% |
35,153
-612,239
| -95% | -$3M |
|
|
GAN
5732
DELISTED
GAN Ltd
GAN
| $125K | ﹤0.01% |
98,410
-93,510
| -49% | -$139K |
|
5733
LXP Industrial Trust 6.5% Series C Preferred Stock
LXP.PRC
$94.5M
| $125K | ﹤0.01% |
2,685
-2,717
| -50% | -$126K |
|
|
HITI
5734
High Tide
HITI
$198M
| $125K | ﹤0.01% |
+61,469
| New | +$110K |
|
5735
Valhi
VHI
$395M
| $124K | ﹤0.01% |
7,238
-11,444
| -61% | -$165K |
|
5736
Greenwich LifeSciences
GLSI
$211M
| $124K | ﹤0.01% |
6,230
+5,670
| +1,013% | +$69.9K |
|
|
CANF
5737
Can-Fite BioPharma American Depositary Shares
CANF
$6.92M
| $124K | ﹤0.01% |
2,790
-1,837
| -40% | -$76.7K |
|
|
ORGN
5738
DELISTED
Origin Materials
ORGN
| $124K | ﹤0.01% |
8,089
-19,737
| -71% | -$342K |
|
5739
Envoy Medical
COCH
$53.9M
| $124K | ﹤0.01% |
31,541
+25,941
| +463% | +$75.9K |
|
|
XYF
5740
X Financial
XYF
$203M
| $124K | ﹤0.01% |
32,000
+3,800
| +13% | +$15.6K |
|
5741
Acrivon Therapeutics
ACRV
$66.8M
| $123K | ﹤0.01% |
17,243
-34,019
| -66% | -$158K |
|
5742
Swan Enhanced Dividend Income ETF
SCLZ
$19.5M
| $122K | ﹤0.01% |
+2,395
| New | +$120K |
|
|
FONR
5743
DELISTED
Fonar
FONR
| $122K | ﹤0.01% |
5,713
+1,501
| +36% | +$31.6K |
|
5744
Westwood Holdings Group
WHG
$184M
| $122K | ﹤0.01% |
9,871
+637
| +7% | +$7.67K |
|
|
NOM
5745
DELISTED
Nuveen Missouri Quality Municipal Income Fund
NOM
| $121K | ﹤0.01% |
11,901
-15,401
| -56% | -$156K |
|
5746
AEON Biopharma
AEON
$12.9M
| $121K | ﹤0.01% |
145
+95
| +190% | +$68.8K |
|
5747
ProShares Ultra Gold
UGL
$653M
| $121K | ﹤0.01% |
6,680
-8,136
| -55% | -$129K |
|
|
VIRX
5748
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $120K | ﹤0.01% |
118,016
-56,666
| -32% | -$41.4K |
|
5749
374Water
SCWO
$39.2M
| $120K | ﹤0.01% |
9,551
-22,380
| -70% | -$288K |
|
5750
Forafric Global
AFRI
$286M
| $120K | ﹤0.01% |
11,615
-10,127
| -47% | -$106K |
|
Similar funds
Morgan Stanley's Q1 2024 Portfolio in Review
As of Q1 2024, Morgan Stanley held 8,154 positions worth $1.25T, down 45% from $2.27T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Morgan Stanley withdrew a net $1.16T in Q1 2024, closing 331 positions and reducing 6,748 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $725M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Morgan Stanley opened a new position in Grayscale Bitcoin Trust worth $270M.
- Morgan Stanley's largest Q1 2024 buy was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M.
- Morgan Stanley added most to Altria Group in Q1 2024, an estimated $428M increase.
- Morgan Stanley's biggest Q1 2024 reduction was Microsoft, cutting an estimated $50.9B.
- Morgan Stanley fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $725M.
- Morgan Stanley's ten largest holdings make up 19% of its $1.25T portfolio in Q1 2024.
- Morgan Stanley opened 333 new positions and closed 331 in Q1 2024.
- Morgan Stanley's portfolio value fell 45% quarter-over-quarter to $1.25T.
Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.